Loomis, Sayles & Company’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.7M | Sell |
|
|||||
|
2025
Q1 | $44.2M | Buy |
|
|||||
|
2024
Q4 | $42.6M | Buy |
|
|||||
|
2024
Q3 | $37.3M | Buy |
|
|||||
|
2024
Q2 | $21.8M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $11K | Sell |
|
|||||
|
2018
Q1 | $10K | Sell |
|
|||||
|
2017
Q4 | $38K | Buy |
|
|||||
|
2017
Q3 | $28K | Buy |
|
|||||
|
2017
Q2 | $8K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $11K | Hold |
|
|||||
|
2016
Q3 | $11K | Hold |
|
|||||
|
2016
Q2 | $13K | Sell |
|
|||||
|
2016
Q1 | $24K | Buy |
|
|||||
|
2015
Q4 | $3K | Buy |
|